LBX Pharmacy Chain Joint Stock Company

SHSE:603883 Stock Report

Market Cap: CN¥13.6b

LBX Pharmacy Chain Future Growth

Future criteria checks 2/6

LBX Pharmacy Chain is forecast to grow earnings and revenue by 16.4% and 14.9% per annum respectively. EPS is expected to grow by 16.1% per annum. Return on equity is forecast to be 16.1% in 3 years.

Key information

16.4%

Earnings growth rate

16.1%

EPS growth rate

Consumer Retailing earnings growth36.4%
Revenue growth rate14.9%
Future return on equity16.1%
Analyst coverage

Good

Last updated05 Sep 2024

Recent future growth updates

Recent updates

LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Sep 06
LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Sep 02
Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Jul 03
Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

Jun 08
Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

May 21
LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Apr 22
There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Earnings and Revenue Growth Forecasts

SHSE:603883 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202635,1471,5472,6653,21711
12/31/202530,0191,3242,4212,97712
12/31/202423,6369191,0051,4502
3/31/202422,5369591,7412,298N/A
12/31/202322,4379292,1092,730N/A
9/30/202322,4418921,5001,841N/A
6/30/202321,9958421,9902,337N/A
3/31/202321,4758352,5582,903N/A
12/31/202220,1767852,0062,314N/A
9/30/202218,1927462,2012,530N/A
6/30/202217,2267201,9102,249N/A
3/31/202216,1986831,5862,112N/A
12/31/202115,6966691,8202,298N/A
9/30/202115,1286661,6542,082N/A
6/30/202114,7416911,5862,058N/A
3/31/202114,3236531,3621,693N/A
12/31/202013,9676211,0531,447N/A
9/30/202013,4136029191,362N/A
6/30/202012,8165756691,042N/A
3/31/202012,2185456341,036N/A
12/31/201911,6635096061,033N/A
9/30/201911,0695054231,033N/A
6/30/201910,56748463990N/A
3/31/20199,9884641883N/A
12/31/20189,47143540913N/A
9/30/20189,015421-30559N/A
6/30/20188,484401288568N/A
3/31/20187,984388236518N/A
12/31/20177,501371N/A498N/A
9/30/20177,036363N/A609N/A
6/30/20176,780343N/A413N/A
3/31/20176,494331N/A420N/A
12/31/20166,094297N/A313N/A
9/30/20165,673285N/A331N/A
6/30/20165,250265N/A280N/A
3/31/20164,850254N/A257N/A
12/31/20154,568241N/A257N/A
9/30/20154,331226N/A217N/A
6/30/20154,178218N/A276N/A
3/31/20154,063212N/A266N/A
12/31/20143,943202N/A247N/A
12/31/20133,321161N/A137N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603883's forecast earnings growth (16.4% per year) is above the savings rate (2.9%).

Earnings vs Market: 603883's earnings (16.4% per year) are forecast to grow slower than the CN market (23.1% per year).

High Growth Earnings: 603883's earnings are forecast to grow, but not significantly.

Revenue vs Market: 603883's revenue (14.9% per year) is forecast to grow faster than the CN market (13.3% per year).

High Growth Revenue: 603883's revenue (14.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603883's Return on Equity is forecast to be low in 3 years time (16.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y